olprinone has been researched along with Complication, Postoperative in 4 studies
olprinone: RN refers to HCl; structure given in first source
| Excerpt | Relevance | Reference |
|---|---|---|
| "The incidence of postoperative atrial fibrillation was significantly lower in the olprinone group than in the placebo group (10% vs 60%, P < ." | 9.20 | A Double-Blind Placebo-Controlled Study of the Effects of Olprinone, a Specific Phosphodiesterase III Inhibitor, for Preventing Postoperative Atrial Fibrillation in Patients Undergoing Pulmonary Resection for Lung Cancer. ( Inoue, M; Maeda, H; Nojiri, T; Okumura, M; Ose, N; Susaki, Y; Takeuchi, Y; Yamamoto, K, 2015) |
| " The rate of post-hepatectomy liver failure frequency tended to be lower in the olprinone group." | 5.24 | Phase I clinical trial of olprinone in liver surgery. ( Fuji, H; Hatano, E; Iguchi, K; Ikeno, Y; Ishii, H; Kobayashi, M; Seo, S; Tanaka, S; Taura, K; Uemoto, S; Ueno, K; Yamanaka, K; Yasuchika, K; Yoh, T, 2017) |
| "The incidence of postoperative atrial fibrillation was significantly lower in the olprinone group than in the placebo group (10% vs 60%, P < ." | 5.20 | A Double-Blind Placebo-Controlled Study of the Effects of Olprinone, a Specific Phosphodiesterase III Inhibitor, for Preventing Postoperative Atrial Fibrillation in Patients Undergoing Pulmonary Resection for Lung Cancer. ( Inoue, M; Maeda, H; Nojiri, T; Okumura, M; Ose, N; Susaki, Y; Takeuchi, Y; Yamamoto, K, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nojiri, T | 1 |
| Yamamoto, K | 1 |
| Maeda, H | 1 |
| Takeuchi, Y | 1 |
| Ose, N | 1 |
| Susaki, Y | 1 |
| Inoue, M | 1 |
| Okumura, M | 1 |
| Fuji, H | 1 |
| Hatano, E | 1 |
| Iguchi, K | 1 |
| Yamanaka, K | 1 |
| Yoh, T | 1 |
| Ikeno, Y | 1 |
| Seo, S | 1 |
| Taura, K | 1 |
| Yasuchika, K | 1 |
| Tanaka, S | 1 |
| Ishii, H | 1 |
| Kobayashi, M | 1 |
| Ueno, K | 1 |
| Uemoto, S | 1 |
| Yamanaka, H | 1 |
| Hayashi, Y | 1 |
| Kamibayashi, T | 1 |
| Mashimo, T | 1 |
| Unoshima, M | 1 |
| Iwasaka, H | 1 |
| Hattori, S | 1 |
| Kitano, T | 1 |
| Noguchi, T | 1 |
3 trials available for olprinone and Complication, Postoperative
| Article | Year |
|---|---|
A Double-Blind Placebo-Controlled Study of the Effects of Olprinone, a Specific Phosphodiesterase III Inhibitor, for Preventing Postoperative Atrial Fibrillation in Patients Undergoing Pulmonary Resection for Lung Cancer.
Topics: Aged; Atrial Fibrillation; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up | 2015 |
Phase I clinical trial of olprinone in liver surgery.
Topics: Aged; Carcinoma, Hepatocellular; Cohort Studies; Female; Hepatectomy; Humans; Imidazoles; Incidence; | 2017 |
Effect of olprinone, a phosphodiesterase III inhibitor, on balance of cerebral oxygen supply and demand during cardiopulmonary bypass.
Topics: Aged; Cardiopulmonary Bypass; Cerebral Cortex; Cerebrovascular Circulation; Dose-Response Relationsh | 2011 |
1 other study available for olprinone and Complication, Postoperative
| Article | Year |
|---|---|
[Effects of loprinone hydrochloride on hemodynamics and respiratory oxygenation in patients after cardiac surgery].
Topics: Aged; Cardiac Output, Low; Cardiotonic Agents; Coronary Artery Bypass; Female; Hemodynamics; Humans; | 1997 |